FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Reto Schumacher

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Procedures

Living Beings

Vaccinia virus

Physiology

Immunologic Memory

Co-author Network

Publications

TOP 3
Laura Bracci; Reto Schumacher; Maurizio Provenzano; Michel Adamina; Rachel Rosenthal; Celia Groeper; Paul Zajac; Giandomenica Iezzi; Enrico Proietti; Filippo Belardelli; Giulio C Spagnoli
Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Michel Adamina; Walter P Weber; Rachel Rosenthal; Reto Schumacher; Paul Zajac; Ulrich Guller; Daniel M Frey; Daniel Oertli; Markus Zuber; Michael Heberer; Giulio C Spagnoli
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Michel Adamina; Ulrich Guller; Laura Bracci; Michael Heberer; Giulio C Spagnoli; Reto Schumacher
Clinical applications of virosomes in cancer immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Reto Schumacher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Laura Bracci; Reto Schumacher; Maurizio Provenzano; Michel Adamina; Rachel Rosenthal; Celia Groeper; Paul Zajac; Giandomenica Iezzi; Enrico Proietti; Filippo Belardelli; Giulio C Spagnoli
Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(5):466-74.
2008: Michel Adamina; Walter P Weber; Rachel Rosenthal; Reto Schumacher; Paul Zajac; Ulrich Guller; Daniel M Frey; Daniel Oertli; Markus Zuber; Michael Heberer; Giulio C Spagnoli
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Contemporary clinical trials 2008;29(2):165-81.
2006: Michel Adamina; Ulrich Guller; Laura Bracci; Michael Heberer; Giulio C Spagnoli; Reto Schumacher
Clinical applications of virosomes in cancer immunotherapy.
Expert opinion on biological therapy 2006;6(11):1113-21.
2006: Walter P Weber; Chantal Feder-Mengus; Alberto Chiarugi; Rachel Rosenthal; Anca Reschner; Reto Schumacher; Paul Zajac; Heidi Misteli; Daniel M Frey; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
European journal of immunology 2006;36(2):296-304.
2006: Michel Adamina; Reto Schumacher; Paul Zajac; Walter P Weber; Rachel Rosenthal; Célia Groeper; Chantal Feder; Rinaldo Zurbriggen; Mario Amacker; Giulio C Spagnoli; Daniel Oertli; Michael Heberer
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy.
Journal of liposome research 2006;16(3):195-204.
2005: Reto Schumacher; Mario Amacker; Danielle Neuhaus; Rachel Rosenthal; Célia Groeper; Michael Heberer; Giulio C Spagnoli; Rinaldo Zurbriggen; Michel Adamina
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.
Vaccine 2005;23(48-49):5572-82.
2005: Urs von Holzen; Michel Adamina; Martin Bolli; Walter P Weber; Paul Zajac; Célia Groeper; Anca Reschner; Chantal Feder; Reto Schumacher; Walter R Marti; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
International journal of cancer. Journal international du cancer 2005;115(2):248-55.
2004: Federica Albo; Antonella Cavazza; Bruno Giardina; Mario Marini; L Giorgio Roda; Reto Schumacher; Giulio C Spagnoli
Degradation of the tumor antigen epitope gp100(280-288) by fibroblast-associated enzymes abolishes specific immunorecognition.
Biochimica et biophysica acta 2004;1671(1-3):59-69.
2004: Reto Schumacher; Michel Adamina; Rinaldo Zurbriggen; Martin Bolli; Elisabetta Padovan; Paul Zajac; Michael Heberer; Giulio C Spagnoli
Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.
Vaccine 2004;22(5-6):714-23.
2004: Michel Adamina; Martin Bolli; Federica Albo; A Cavazza; Paul Zajac; Elisabetta Padovan; Reto Schumacher; Anca Reschner; Chantal Feder; Walter R Marti; Daniel Oertli; Michael Heberer; Giulio C Spagnoli
Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes.
British journal of cancer 2004;90(1):263-9.
2002: Daniel Oertli; Walter R Marti; Paul Zajac; Christoph Noppen; Thomas Kocher; Elisabetta Padovan; Michel Adamina; Reto Schumacher; Felix Harder; Michael Heberer; Giulio C Spagnoli
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.
Human gene therapy 2002;13(4):569-75.